AKBM.OL OSL
Aker BioMarine AS
1W: -6.2%
1M: -23.5%
3M: +2.0%
YTD: +5.8%
1Y: +22.1%
3Y: +274.8%
5Y: +244.6%
kr 122.00 ($12.69)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$5M
-62.9% ▼
Capital Expenditures
$6M
+63.9% ▲
5Y CAGR: -23.3%
Free Cash Flow
-$2M
+66.3% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$11K
+100.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | $10M | -$9M | $180M | -$3M |
| Depreciation & Amort. | $51M | $49M | $50M | $44M | $19M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$53M | -$38M | $23M | -$16M | -$6M |
| Other Non-Cash Items | $10M | -$6M | -$17M | -$196M | -$5M |
| Operating Cash Flow | $729K | $15M | $47M | $12M | $5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$81M | -$46M | -$46M | -$17M | -$9M |
| Acquisitions (Net) | -$10K | -$11M | $0 | -$700K | -$8M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $2M | $800K | -$3M | $398M | -$618K |
| Investing Cash Flow | -$79M | -$56M | -$49M | $379M | -$17M |
| — Financing Activities — | |||||
| Net Debt Issuance | $79M | $52M | $7M | -$34M | $15M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$373M | $0 |
| Other Financing | $35K | $0 | $0 | $4M | $0 |
| Financing Cash Flow | $79M | $52M | $7M | -$404M | $15M |
| Net Change in Cash | $454K | $11M | $5M | -$12M | $11K |
| Cash End of Period | $11M | $22M | $28M | $15M | $17M |
| Free Cash Flow | -$80M | -$31M | -$2M | -$5M | -$2M |